Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
Published in Brain Stimulation, the Baycrest/Rotman team used fMRI to show rapid CSF dynamics changes after brief pulsed PBM ...
Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.
The Healthy @Reader's Digest on MSN
I was on 11 medications for autoimmune symptoms and chronic pain—then I started red light therapy, and my reality changed
After experiencing her own personal health improvements through red light therapy, she opened her location in 2021 to help ...
News-Medical.Net on MSN
Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN ...
Scientists identify new species of denitrifying endosymbionts in wastewater, highlighting their global prevalence – with an ...
A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback